TY - JOUR
T1 - Conversion of pericytes to neurons
T2 - A new guest at the reprogramming convention
AU - Nivet, Emmanuel
AU - Sancho-Martinez, Ignacio
AU - Izpisua Belmonte, Juan Carlos
N1 - Funding Information:
The authors thank May Schwarz for administrative support. The laboratory of JCIB is supported by grants from Fundacion Cellex, CIBER the G Harold and Leila Y Mathers Charitable Foundation, The Leona M and Harry B Helmsley Charitable Trust, and MINECO.
PY - 2013
Y1 - 2013
N2 - Reprogramming strategies allow for the generation of virtually any cell type of the human body, which could be useful for cell-based therapy. Among the different reprogramming technologies available, direct lineage conversion offers the possibility to change the phenotype of a cell type to another one without pushing cells backwards to a plastic/proliferative stage. This approach has raised the possibility to apply a similar process in vivo in order to compensate for functional cell loss. Historically, the cerebral tissue is a prime choice for developing cell-based treatments. As local pericyte accumulation is observed after central nervous system injury, it can be reasoned that this cell type might be a good candidate for the conversion into new neurons in vivo. In this article, and by focusing on recent observations from Karow and colleagues demonstrating the possibility to convert human brain-derived pericytes into functional neurons, we present a brief overview of the state of the art and attempt to offer perspective as to how these interesting laboratory findings could be translated in the clinic.
AB - Reprogramming strategies allow for the generation of virtually any cell type of the human body, which could be useful for cell-based therapy. Among the different reprogramming technologies available, direct lineage conversion offers the possibility to change the phenotype of a cell type to another one without pushing cells backwards to a plastic/proliferative stage. This approach has raised the possibility to apply a similar process in vivo in order to compensate for functional cell loss. Historically, the cerebral tissue is a prime choice for developing cell-based treatments. As local pericyte accumulation is observed after central nervous system injury, it can be reasoned that this cell type might be a good candidate for the conversion into new neurons in vivo. In this article, and by focusing on recent observations from Karow and colleagues demonstrating the possibility to convert human brain-derived pericytes into functional neurons, we present a brief overview of the state of the art and attempt to offer perspective as to how these interesting laboratory findings could be translated in the clinic.
UR - http://www.scopus.com/inward/record.url?scp=84872312720&partnerID=8YFLogxK
U2 - 10.1186/scrt150
DO - 10.1186/scrt150
M3 - Review article
C2 - 23312036
AN - SCOPUS:84872312720
SN - 1757-6512
VL - 4
JO - Stem Cell Research and Therapy
JF - Stem Cell Research and Therapy
IS - 1
M1 - 2
ER -